Characteristic | NIBP Monitored Patients (N = 3,961) | NIBP Monitored Patients With EHI (N = 380) | IAP Monitored Patients (N = 672) | IAP Monitored Patients With EHI (N = 312) |
---|---|---|---|---|
Sex | ||||
 Male, n (%) | 2152 (54.4%) | 190 (50%) | 390 (58%) | 182 (58.3%) |
 Female, n (%) | 1807 (45.6%) | 190 (50%) | 282 (42%) | 130 (41.7%) |
 Unknown or not reported, n (%) | 2 (0.0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Age (Years) | ||||
 Mean (SD) | 60.4 (18.1) | 61.1 (17.4) | 60.6 (15.8) | 61.4 (16.6) |
 Min, Max | 18, 100 | 18, 99 | 18, 90 | 18, 90 |
Race, n (%) | ||||
 White | 3188 (80.5%) | 313 (82.4%) | 529 (78.8%) | 245 (78.5%) |
 Black or African American | 524 (13.2%) | 53 (13.9%) | 91 (13.6%) | 44 (14.1%) |
 Asian | 86 (2.2%) | 4 (1.0%) | 14 (2.1%) | 8 (2.6%) |
 Unknown or not reported | 40 (1.0%) | 5 (1.2%) | 19 (2.8%) | 8 (2.6%) |
 American Indian or Alaska Native | 20 (0.5%) | 1 (0.2%) | 4 (0.6%) | 2 (0.6%) |
 Native Hawaiian and Other Pacific Islander | 3 (0.1%) | 0 (0.0%) | 1 (0.2%) | 1 (0.3%) |
 Other | 97 (2.5%) | 5 (1.2%) | 14 (1.9%) | 4 (1.3%) |
Ethnicity, n (%) | ||||
 Hispanic | 114 (2.9%) | 7 (1.8%) | 16 (2.2%) | 8 (2.6%) |
 Non-Hispanic | 3791 (95.7%) | 367 (96.6%) | 635 (94.6%) | 291 (93.3%) |
 Unknown or not reported | 56 (1.4%) | 6 (1.6%) | 21 (3.2%) | 13 (4.1%) |